BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23952524)

  • 1. Estrogen therapy in gynecological cancer survivors.
    Guidozzi F
    Climacteric; 2013 Dec; 16(6):611-7. PubMed ID: 23952524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy for women previously treated for endometrial cancer.
    Edey KA; Rundle S; Hickey M
    Cochrane Database Syst Rev; 2018 May; 5(5):CD008830. PubMed ID: 29763969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing menopausal symptoms after gynecological cancer.
    Michaelson-Cohen R; Beller U
    Curr Opin Oncol; 2009 Sep; 21(5):407-11. PubMed ID: 19587594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
    Rees M; Angioli R; Coleman RL; Glasspool R; Plotti F; Simoncini T; Terranova C
    Maturitas; 2020 Apr; 134():56-61. PubMed ID: 32059825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Options for hormone therapy in women who have had a hysterectomy.
    Haney AF; Wild RA
    Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of hormone replacement therapy in gynaecological cancer survivors.
    Biliatis I; Thomakos N; Rodolakis A; Akrivos N; Zacharakis D; Antsaklis A
    J Obstet Gynaecol; 2012 May; 32(4):321-5. PubMed ID: 22519472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in cancer survivors: Utopia?
    Angioli R; Luvero D; Armento G; Capriglione S; Plotti F; Scaletta G; Lopez S; Montera R; Gatti A; Serra GB; Benedetti Panici P; Terranova C
    Crit Rev Oncol Hematol; 2018 Apr; 124():51-60. PubMed ID: 29548486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral oophorectomy and premature menopause.
    Hendrix SL
    Am J Med; 2005 Dec; 118 Suppl 12B():131-5. PubMed ID: 16414338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
    Rees M; Angioli R; Coleman RL; Glasspool RM; Plotti F; Simoncini T; Terranova C
    Int J Gynecol Cancer; 2020 Apr; 30(4):428-433. PubMed ID: 32046979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
    Mortimer JE
    Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy in breast cancer patients and survivors.
    Del Priore G; Hatami M
    Curr Womens Health Rep; 2003 Apr; 3(2):165-9. PubMed ID: 12628087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R; Theriault RL
    J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal replacement therapy after gynaecological cancer.
    Biglia N; Mariani L; Marenco D; Robba C; Peano E; Kubatzki F; Sismondi P
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):191-6. PubMed ID: 17068403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy in gynecologic cancer survivors: why not?
    Ibeanu O; Modesitt SC; Ducie J; von Gruenigen V; Agueh M; Fader AN
    Gynecol Oncol; 2011 Aug; 122(2):447-54. PubMed ID: 21474167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and combined hormone therapy for women after genital malignancies: a review.
    Levgur M
    J Reprod Med; 2004 Oct; 49(10):837-48. PubMed ID: 15568410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy (HT) in patients with breast cancer.
    Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
    Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.